Your browser does not support JavaScript!

Home    Collections    Type of Work    Post-graduate theses  

Post-graduate theses

Current Record: 9 of 4898

Back to Results Previous page
Next page
Add to Basket
[Add to Basket]
Identifier 000431732
h
Title The role of inflammasome during immunotherapy responses in cancer
Alternative Title Ο ρόλος του φλεγμονοσώματος κατά τη διάρκεια των ανοσοθεραπευτικών αποκρίσεων στον καρκίνο
Author Παπαφράγκος, Ιωσήφ
Thesis advisor Βεργίνης, Παναγιώτης
Reviewer Καρδάσης, Δημήτριος
Μπερτσιάς, Γεώργιος
Abstract Chronic inflammation is considered one of the hallmarks of cancer initiation and progression and is a critical modulator of carcinogenesis through secretion of inflammatory cytokines, which leads to the formation of an inflammatory and immunosuppressive tumor microenvironment (TME). Chronic inflammation in TME in tumorbearing patients has been accused to induce the accumulation and retention of highly immunosuppressive myeloid cells, such as myeloid-derived suppressor cells (MDSCs), through the aberrant activation of myelopoiesis resulting in their expansion and recruitment. In consistence with this, the highly inflammatory and immunosuppressive TME becomes a hotbed of immunologic activity promoting tumor growth and development, as it provides an immunosuppressive shield that protects the tumor from patient’s immune system and immunotherapy. In this process, the inflammasome plays a crucial role. The inflammasome constitutes an innate immune sensor that regulates and controls the homeostatic innate immune pathways and is a critical for the production of active IL-1β, a potent inflammatory cytokine. Although inflammasomes are essential for host defense against pathogens and contribute to autoimmune diseases, their role in tumor progression remains controversial. Inflammasomes and their effectors are able to shape the tumor milieu through their contribution to inflammation and immune responses, affecting thus the development, progression and treatment of cancer, which depicts the diverse roles of inflammasomes in modulating carcinogenesis and their potential targeting in translational research. For the present Master Thesis, we aimed to investigate how the NLRP3 inflammasome and consequently IL-1β shapes tumor growth, anti-tumor immune response and immunotherapy responses. Herein, we provide evidence for the crucial role of the NLRP3 inflammasome pathway in the establishment of melanoma. We demonstrate a pro-tumorigenic role for inflammasome’s effector IL-1β cytokine, whose presence in TME and peripheral lymphoid organs of melanoma-bearing mice is associated with tumor progression and development. Activation of the NLRP3 inflammasome pathway in myeloid cell compartment provides an inflammatory microenvironment promoting melanoma tumor progression. Finally, our data suggest that inhibition of NLRP3 inflammasome attenuates melanoma tumor growth and alters the immune cell milieu. Collectively, these findings delineate a pivotal role of NRLP3 inflammasome in carcinogenesis and offer a better mechanistic insight of how it influences tumor progression and anti-tumor immune responses, which will undoubtedly open new avenues for translational research and the development of more efficacious immunotherapeutic approaches
Language English
Subject NLRP3 φλεγμονόσωμα
Ιντερλευκίνη -1 Βητα (IL-1B)
Κατασταλτικά κύτταρα μυελικής σειράς (MDSCs)
Μικροπεριβάλλον όγκου
Issue date 2020-08-05
Collection   Faculty/Department--School of Medicine--Department of Medicine--Post-graduate theses
  Type of Work--Post-graduate theses
Permanent Link https://elocus.lib.uoc.gr//dlib/2/3/e/metadata-dlib-1599463779-2335-8036.tkl Bookmark and Share
Views 40

Digital Documents
No preview available

No permission to view document.
It won't be available until: 2021-02-05